BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

310 related articles for article (PubMed ID: 25318897)

  • 1. Role of biofilm in children with recurrent upper respiratory tract infections.
    Nazzari E; Torretta S; Pignataro L; Marchisio P; Esposito S
    Eur J Clin Microbiol Infect Dis; 2015 Mar; 34(3):421-9. PubMed ID: 25318897
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Probiotics Streptococcus salivarius 24SMB and Streptococcus oralis 89a interfere with biofilm formation of pathogens of the upper respiratory tract.
    Bidossi A; De Grandi R; Toscano M; Bottagisio M; De Vecchi E; Gelardi M; Drago L
    BMC Infect Dis; 2018 Dec; 18(1):653. PubMed ID: 30545317
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recurrent upper airway infections and bacterial biofilms.
    Galli J; Ardito F; Calò L; Mancinelli L; Imperiali M; Parrilla C; Picciotti PM; Fadda G
    J Laryngol Otol; 2007 Apr; 121(4):341-4. PubMed ID: 17083751
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of N-acetylcysteine on biofilms: Implications for the treatment of respiratory tract infections.
    Blasi F; Page C; Rossolini GM; Pallecchi L; Matera MG; Rogliani P; Cazzola M
    Respir Med; 2016 Aug; 117():190-7. PubMed ID: 27492531
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hijacking of immune defences by biofilms: a multifront strategy.
    Campoccia D; Mirzaei R; Montanaro L; Arciola CR
    Biofouling; 2019 Nov; 35(10):1055-1074. PubMed ID: 31762334
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combination and nanotechnology based pharmaceutical strategies for combating respiratory bacterial biofilm infections.
    Zhang L; Bera H; Wang H; Wang J; Guo Y; Shi C; Cun D; Moser C; Høiby N; Yang M
    Int J Pharm; 2022 Mar; 616():121507. PubMed ID: 35085729
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of biofilms in chronic inflammatory diseases of the upper airways.
    Calò L; Passàli GC; Galli J; Fadda G; Paludetti G
    Adv Otorhinolaryngol; 2011; 72():93-6. PubMed ID: 21865700
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevention of recurrent respiratory tract infections in children using a ribosomal immunotherapeutic agent: a clinical review.
    Bousquet J; Fiocchi A
    Paediatr Drugs; 2006; 8(4):235-43. PubMed ID: 16898854
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biofilms and infections of the upper respiratory tract.
    Pintucci JP; Corno S; Garotta M
    Eur Rev Med Pharmacol Sci; 2010 Aug; 14(8):683-90. PubMed ID: 20707288
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of ribomunyl((r)) in the prevention of recurrent respiratory tract infections in adults : overview of clinical results.
    Bousquet J; Oliveri D
    Treat Respir Med; 2006; 5(5):317-24. PubMed ID: 16928145
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phage Lysins for Fighting Bacterial Respiratory Infections: A New Generation of Antimicrobials.
    Vázquez R; García E; García P
    Front Immunol; 2018; 9():2252. PubMed ID: 30459750
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sublingual therapeutic immunization with a polyvalent bacterial preparation in patients with recurrent respiratory infections: immunomodulatory effect on antigen-specific memory CD4+ T cells and impact on clinical outcome.
    Alecsandru D; Valor L; Sánchez-Ramón S; Gil J; Carbone J; Navarro J; Rodríguez J; Rodríguez-Sainz C; Fernández-Cruz E
    Clin Exp Immunol; 2011 Apr; 164(1):100–7. PubMed ID: 21391984
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Three clinically distinct chronic pediatric airway infections share a common core microbiota.
    van der Gast CJ; Cuthbertson L; Rogers GB; Pope C; Marsh RL; Redding GJ; Bruce KD; Chang AB; Hoffman LR
    Ann Am Thorac Soc; 2014 Sep; 11(7):1039-48. PubMed ID: 24597615
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Bacterial biofilm identification in the rhinopharingeal mucosa of children with recurrent infection of the upper respiratory tract and otitis media].
    Galli J; Calò L; Ardito F; Imperiali M; Passali GC; Carnevale N; Fadda G; Paludetti G
    Pediatr Med Chir; 2008; 30(1):31-4. PubMed ID: 18491676
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Microbial epidemiology and carriage studies for the evaluation of vaccines.
    Coughtrie AL; Jefferies JM; Cleary DW; Doncaster CP; Faust SN; Kraaijeveld AR; Moore MV; Mullee MA; Roderick PJ; Webb JS; Yuen HM; Clarke SC
    J Med Microbiol; 2019 Oct; 68(10):1408-1418. PubMed ID: 31418679
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Concurrent serious bacterial infections in 2396 infants and children hospitalized with respiratory syncytial virus lower respiratory tract infections.
    Purcell K; Fergie J
    Arch Pediatr Adolesc Med; 2002 Apr; 156(4):322-4. PubMed ID: 11929363
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Upper respiratory tract infections.
    Moore DA; Sharland M; Friedland JS
    Curr Opin Pulm Med; 1999 May; 5(3):157-63. PubMed ID: 10228740
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antimicrobial resistance in bacterial pathogens among hospitalized children with community acquired lower respiratory tract infections in Dongguan, China (2011-2016).
    He X; Xie M; Li S; Ye J; Peng Q; Ma Q; Lu X; Zhong B
    BMC Infect Dis; 2017 Sep; 17(1):614. PubMed ID: 28893195
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evolving concepts in biofilm infections.
    Hall-Stoodley L; Stoodley P
    Cell Microbiol; 2009 Jul; 11(7):1034-43. PubMed ID: 19374653
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunization with a Biofilm-Disrupting Nontypeable
    Bailey MT; Lauber CL; Novotny LA; Goodman SD; Bakaletz LO
    mSphere; 2020 Apr; 5(2):. PubMed ID: 32295873
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.